Dr. Joseph Strouthos was born and raised in Larnaca, Cyprus. He graduated from the American Academy in Larnaca in 2003 and after completing his military service went to the Czech Republic to study medicine. He then worked in Germany, where he obtained a degree in radiotherapy oncology and completed his doctorate, during which time he was able to work with leading scientists in the field, including Professor Zamboglou, and to pursue scientific work before joining the Medical Team at the German Oncology. He lives in his home town with his wife and daughter.
My goal is to achieve thorough training in modern radiotherapy techniques, so that I can offer optimal treatment to people in need.
More about Joseph Strouthos
Oct. 2005 – July. 2011: Medicine, 1st Medical School at the Charles University, Prague, Czech Republic (MUDr).
July 2015: Diploma in «Application of Low level Laser Therapy» -Thor® Company, United Kingdom.
February 2018: PhD Graduate – Goethe University of Frankfurt, Germany. Thesis title: “Interstitial Brachytherapy of prostate as monotherapy”.
Jan. 2013 – Dec. 2013: Resident doctor – Radiation Oncology Department for Radiation Oncology, Klinikum Chemnitz GmbH, Germany (Head of Department – Dr. D. Baaske)
Jan. 2014 – Sep. 2016: Resident doctor – Radiation Oncology Department of Interdisciplinary Oncology, Sana Klinikum Offenbach Germany (Head of Department – Prof. Dr. Dr. N. Zamboglou)
Oct. 2016 – May 2018: Resident doctor – Radiation Oncology Department of Radiation Oncology, University Clinic Freiburg, Medical Center, Germany (Head of Department – Prof. Dr. A.-L. Grosu)
May 2018 – August 2018: Consultant – Radiation Oncology Department of Radiation Oncology, University Clinic Freiburg, Medical Center, Germany (Head of Department – Prof. Dr. A.-L. Grosu)
Since August 2018: Consultant – Radiation Oncology Department of Radiation Oncology, German Oncology Center, Limassol, Cyprus
Since December 2016: Recruiter, University Clinic Freiburg – “CAO/ARO/AIO-12” Phase II/III trial for induction chemotherapy prior or after neoadjuvant RCTx in rectal cancer patients
Since December 2016: Recruiter, University Clinic Freiburg – “HERACLES” Phase I/II trial for non-resectable hepatocellular carcinoma treated either with SBRT or RFA
Since April 2018: Joint project with Novocure – HEPANOVA -Phase II trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma
Jul. 2015: Certificate „Application of Low level Laser Therapy“ – Thor® Company
Nov.2014 – Feb. 2018: Doctorate, Goethe University Frankfurt – Topic: “HDR-brachytherapy as monotherapy in patients with localized prostate cancer”
Jan.2016 – Sep.2016: Lecturer, Sana Klinikum Offenbach, Germany, School for Radiographers
Oct. 2016: Lecturer, Medical Center – University of Freiburg, Medical students
Feb. 2017: Certificate of “Good Clinical Practice” – GCP as “Primary Investigator”
The role of high dose rate brachytherapy in gleason score 7 prostate cancer: Romulus and Remus Strouthos I, Chatzikonstantinou G, Ferentinos K, Karagiannis E, Zamboglou N, Tselis N. In preparation
Phase 2 HEPANOVA trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma Grosu AL, Gkika E, Brunner T, Strouthos I, Weinberg U Annals of Oncology, Volume 30, Issue Supplement_4, July 2019
Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme Chatzikonstantinou G, Ulrich P, Archavlis E, Zamboglou N, Strouthos I, Zoga E, Baltas D, Tselis N J Contemp Brachytherapy 2019; 11, 3: 215–220
Repeated SBRT for in- and out-of-field recurrences in the liver. Gkika E, Strouthos I, Kirste S, Adebahr S, Schultheiss M, Bettinger D, Fritsch R, Brass V, Maruschke L, Neeff HP, Lang SA, Nestle U, Grosu AL, Brunner TB. Strahlenther Onkol. 2018 Oct.
CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience. Chatzikonstantinou G, Zamboglou N, Archavlis E, Strouthos I, Zoga E, Milickovic N, Hilaris B, Baltas D, Rödel C, Tselis N. Strahlenther Onkol. 2018 Dec
Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis. Schmidt-Hegemann NS, Stief C, Kim TH, Eze C, Kirste S, Strouthos I, Li M, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Grosu AL, Ganswindt U, Belka C, Meyer PT, Zamboglou C. J Nucl Med. 2018 Jul
Inverse planning and inverse implanting for breast interstitial brachytherapy. Introducing a new anatomy specific breast interstitial template (ASBIT). Karagiannis E, Leczynski A, Tselis N, Psanis E, Steckenreiter O, Milickovic N, Bon D, Strouthos I, Ferentinos K, Hass P, Gademann G, Baltas D, Zamboglou N. Radiother Oncol. 2018 Sep
Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer. Strouthos I, Chatzikonstantinou G, Zamboglou N, Milickovic N, Papaioannou S, Bon D, Zamboglou C, Rödel C, Baltas D, Tselis N. Radiother Oncol. 2018 Aug.
HEPANOVA: A phase II trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma Grosu AL, Strouthos I, Brunner T, Weinberg U Cancer Research 2018 Apr.
Safety of repeated stereotactic body radiotherapy (SBRT) for recurrent liver malignancies Gkika E, Strouthos I, Adebahr S, Kirste S, Bettinger D, Fritsch R, Brass V, Maruschke L, Neeff HP, Lang SA, Nestle U, Grosu AL, Brunner TB Radiother Oncol. 2018 Apr.
Interobserver and interfraction variability using free-breathing cbCT for SBRT of the upper abdomen. Nicosia L, Brunner T, Popp I, Gkika E, Capilli F, Rischke HC, Volegova-Neher N, Thomsen A, Strouthos I, Grosu AL, Kirste S. Radiotherapy and Oncology April 2018. 127:S790-S791
High dose rate brachytherapy as monotherapy for localised prostate cancer. Strouthos I, Tselis N, Chatzikonstantinou G, Butt S, Baltas D, Bon D, Milickovic N, Zamboglou N. Radiother Oncol. 2018 Feb
High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy: A systematic review. Chatzikonstantinou G, Zamboglou N, Rödel C, Zoga E, Strouthos I, Butt SA, Tselis N. Strahlenther Onkol. 2017 Sep.
Photobiomodulation therapy for the management of radiation-induced dermatitis:
A single-institution experience of adjuvant radiotherapy in breast cancer patients after breast conserving surgery. Strouthos I, Chatzikonstantinou G, Tselis N, Bon D, Karagiannis E, Zoga E, Ferentinos K, Maximenko J, Nikolettou-Fischer V, Zamboglou N. Strahlenther Onkol. 2017 Jun.
Docetaxel-induced radiation recall dermatitis: A case report and literature review. Strouthos I, Tselis N, Zamboglou N. Strahlenther Onkol. 2016 Oct
“Every human life deserves only the best medical care”